121 related articles for article (PubMed ID: 17292867)
41. Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases.
Kinoh H; Inoue M; Washizawa K; Yamamoto T; Fujikawa S; Tokusumi Y; Iida A; Nagai Y; Hasegawa M
Gene Ther; 2004 Jul; 11(14):1137-45. PubMed ID: 15085175
[TBL] [Abstract][Full Text] [Related]
42. Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells.
Capobianco A; Manfredi AA; Monno A; Rovere-Querini P; Rugarli C
J Immunother; 2008 Jun; 31(5):458-65. PubMed ID: 18463539
[TBL] [Abstract][Full Text] [Related]
43. Severe impairment of dendritic cell allostimulatory activity by Sendai virus vectors is overcome by matrix protein gene deletion.
Armeanu S; Bitzer M; Smirnow I; Bossow S; Appel S; Ungerechts G; Bernloehr C; Neubert WJ; Lauer UM; Brossart P
J Immunol; 2005 Oct; 175(8):4971-80. PubMed ID: 16210599
[TBL] [Abstract][Full Text] [Related]
44. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
Tan XH; Wan YH
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382
[TBL] [Abstract][Full Text] [Related]
45. Sphingosine kinase inhibitor suppresses a Th1 polarization via the inhibition of immunostimulatory activity in murine bone marrow-derived dendritic cells.
Jung ID; Lee JS; Kim YJ; Jeong YI; Lee CM; Baumruker T; Billlich A; Banno Y; Lee MG; Ahn SC; Park WS; Han J; Park YM
Int Immunol; 2007 Apr; 19(4):411-26. PubMed ID: 17307797
[TBL] [Abstract][Full Text] [Related]
46. Anti-tumor effects of fusion cells of type 1 dendritic cells and Meth A tumor cells using hemagglutinating virus of Japan-envelope.
Yanai S; Adachi Y; Fuijisawa J; Jiang S; Okigaki M; Shi M; Shima C; Imai Y; Kwon AH; Ikehara S
Int J Oncol; 2009 Aug; 35(2):249-55. PubMed ID: 19578737
[TBL] [Abstract][Full Text] [Related]
47. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
[TBL] [Abstract][Full Text] [Related]
48. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
[TBL] [Abstract][Full Text] [Related]
49. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
Wu JQ; Zhao WH; Li Y; Zhu B; Yin KS
Virology; 2007 Nov; 368(2):309-16. PubMed ID: 17675129
[TBL] [Abstract][Full Text] [Related]
50. [New technologies for immunotherapy against cancer: development of cell expansion technology and viruses as immune boosters].
Harada Y; Yonemitsu Y
Yakugaku Zasshi; 2010 Nov; 130(11):1519-26. PubMed ID: 21048412
[TBL] [Abstract][Full Text] [Related]
51. [Antitumor efficacy of fusion cells from esophageal carcinoma cells and dendritic cells as a vaccine in vitro].
Deng YJ; Xia JC; Zhou J; Wang QJ; Zhang PY; Zhang LJ; Rong TH
Ai Zheng; 2007 Feb; 26(2):137-41. PubMed ID: 17298741
[TBL] [Abstract][Full Text] [Related]
52. Validation of recombinant Sendai virus in a non-natural host model.
Griesenbach U; McLachlan G; Owaki T; Somerton L; Shu T; Baker A; Tennant P; Gordon C; Vrettou C; Baker E; Collie DD; Hasegawa M; Alton EW
Gene Ther; 2011 Feb; 18(2):182-8. PubMed ID: 20962870
[TBL] [Abstract][Full Text] [Related]
53. [Unveiling antigens in a non-immunogenic spontaneous murine tumor using a dendritic cell based vaccine].
Reffo VL; Chiarella P; Bruzzo J; Bustuoabad OD; Ruggiero RA
Medicina (B Aires); 2008; 68(4):301-4. PubMed ID: 18786887
[TBL] [Abstract][Full Text] [Related]
54. Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors.
Nagaraj S; Pisarev V; Kinarsky L; Sherman S; Muro-Cacho C; Altieri DC; Gabrilovich DI
J Immunother; 2007; 30(2):169-79. PubMed ID: 17471164
[TBL] [Abstract][Full Text] [Related]
55. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.
Cho HI; Kim EK; Park SY; Lee SK; Hong YK; Kim TG
Cancer Lett; 2007 Dec; 258(2):189-98. PubMed ID: 17931768
[TBL] [Abstract][Full Text] [Related]
56. Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells.
Tomihara K; Kato K; Masuta Y; Nakamura K; Uchida H; Sasaki K; Tanaka T; Huang J; Hiratsuka H; Hamada H
Gene Ther; 2008 Feb; 15(3):203-13. PubMed ID: 17989706
[TBL] [Abstract][Full Text] [Related]
57. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
58. Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybrids.
Lee WT; Tan C; Koski G; Shu S; Cohen P
Head Neck; 2010 Sep; 32(9):1209-16. PubMed ID: 20054852
[TBL] [Abstract][Full Text] [Related]
59. Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection.
Bedsaul JR; Zaritsky LA; Zoon KC
J Interferon Cytokine Res; 2016 Nov; 36(11):652-665. PubMed ID: 27508859
[TBL] [Abstract][Full Text] [Related]
60. Analysis of innate immune responses in a model of IgA nephropathy induced by Sendai virus.
Yamashita M; Chintalacharuvu SR; Kobayashi N; Nedrud JG; Lamm ME; Tomino Y; Emancipator SN
Contrib Nephrol; 2007; 157():159-63. PubMed ID: 17495456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
